martes, 16 de enero de 2024

The Lancet Oncology in conversation with Shankar Shiva on stereotactic body radiotherapy for primary renal cell carcinoma

https://thelancetoncology.buzzsprout.com/1391338/14180304-shankar-shiva-on-stereotactic-body-radiotherapy-for-primary-renal-cell-carcinoma?utm_campaign=update-lanonc&utm_medium=email&_hsmi=290040916&_hsenc=p2ANqtz-_HaXLRJ08QGSZYBsOUBVBw9YT_LB_QLq_jeDf8Ey8FTLIyapZnmpCu89Tb1vC4a6QH9iLGiXmD9WxnN5eTWqxEFuY0Pw&utm_content=289772750&utm_source=hs_email Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS) https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00513-2/fulltext?dgcid=hubspot_update_feature_updatealerts_lanonc%2F&utm_campaign=update-lanonc&utm_medium=email&_hsmi=290040916&_hsenc=p2ANqtz-_opYT7hue691OQGCDaIbmn8OVAgtDJP1XnENl5vfJ6YEb77089BU1l3x0XBiizR-BYyaT7r-4vPPbY3U7fBUQmqOh5lg&utm_content=289772750&utm_source=hs_email

No hay comentarios:

Publicar un comentario